CLINSQUARE: CLINICAL RESEARCH COURSES
Wednesday, May 14, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

BMS Announces Settlement of U.S. Patent Litigation for REVLIMID® With Dr. Reddy’s

admin - 0
September 17, 2020: "Bristol Myers Squibb announced that its wholly owned subsidiary, Celgene, and Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, DRL)...

Novartis reported data from the Phase III COMBI-AD study(Tafinlar® + Mekinist®)

admin - 0
September 16, 2020: "Novartis announced previously reported data from the Phase III COMBI-AD study were published in The New England Journal of Medicine.  The study shows...

AstraZeneca acquires oral PCSK9 inhibitor programme from Dogma Therapeutics

admin - 0
September 17, 2020: "AstraZeneca has entered into an agreement with Dogma Therapeutics to acquire its preclinical oral PCSK9 inhibitor programme. The Company aims to...

Combining two precision medicines can treat drug-resistant cancers

admin - 0
"Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical...

Coronavirus (COVID-19) Update: Daily Roundup September 15, 2020

admin - 0
September 15, 2020: "The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: As part of...

BioNTech to Receive up to €375M in Funding to Support COVID-19 Vaccine

admin - 0
September 15, 2020: "BioNTech SE announced that it will receive a grant of up to 375 million Euro from an initiative by the German Federal...

Periodic safety update reports (PSURs) in EU

admin - 0
"A Periodic Safety Update Report is a Pharmacovigilance document which is intended to provide an evaluation of a medicinal product's risk-benefit balance at specified...

Novartis reports Phase III trial of Beovu® versus aflibercept for DME

admin - 0
September 14, 2020: "Novartis reported the first interpretable results of the Phase III KITE study, assessing the efficacy and safety of Beovu® (brolucizumab) 6...

FDA grants Dupixent® Breakthrough Therapy designation for eosinophilic esophagitis

admin - 0
September 14, 2020: "FDA has granted Breakthrough Therapy designation to Dupixent® (dupilumab) for the treatment of patients 12 years and older with eosinophilic esophagitis (EoE)....

Oxford coronavirus vaccine clinical trials resumed in the UK

admin - 0
September 12, 2020: "Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory...

Minnetronix Medical Gets FDA Clearance on Innovative Neurosurgical Access Platform

admin - 0
September 9, 2020: "Minnetronix Medical, the company known for 25 years of developing and manufacturing products for medical device companies throughout the world announced...

AstraZeneca’s Fasenra shows benefit in chronic rhinosinusitis with nasal polyps

admin - 0
September 10, 2020: "High-level results from the OSTRO Phase III trial showed AstraZeneca’s Fasenra (benralizumab) compared with placebo demonstrated a statistically significant improvement in the size...
1...121314...65Page 13 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved